Capital Increase in Genmab as a Result of Employee Warrant Exercise
Company Announcement
Copenhagen, Denmark; February 28, 2018 — Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 65,419 shares as a consequence of the exercise of employee warrants.
The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:
• 220 shares at DKK 40.41,
• 1,800 shares at DKK 68.65,
• 3,625 shares at DKK 80.55,
• 350 shares at DKK 210,
• 250 shares at DKK 220.40,
• 18,813 shares at DKK 225.90,
• 200 shares at DKK 231.50,
• 1,250 shares at DKK 234,
• 1,250 shares at DKK 246,
• 21,535 shares at DKK 254,
• 6,850 shares at DKK 272,
• 5,188 shares at DKK 337.40,
• 88 shares at DKK 466.20, and
• 4,000 shares at DKK 939.50.
Proceeds to the company are approximately DKK 18.3 million. The increase corresponds to approx. 0.11% of the company's share capital.